Results 211 to 220 of about 180,865 (263)
Some of the next articles are maybe not open access.
Animal Reproduction Science
Programmed cell death (PD) ligand 1 (PDL1) and PDL2 and their receptor PD1 play critical roles in immunity, and an involvement of the PDL1/PDL2-PD1 signaling system in the immune tolerance during pregnancy has been suggested in humans. However, the role of the PDL1/PDL2-PD1 signaling system at the maternal-conceptus interface has not been studied in ...
Inkyu Yoo +5 more
openaire +2 more sources
Programmed cell death (PD) ligand 1 (PDL1) and PDL2 and their receptor PD1 play critical roles in immunity, and an involvement of the PDL1/PDL2-PD1 signaling system in the immune tolerance during pregnancy has been suggested in humans. However, the role of the PDL1/PDL2-PD1 signaling system at the maternal-conceptus interface has not been studied in ...
Inkyu Yoo +5 more
openaire +2 more sources
Pathobiology
Introduction: This study aimed to evaluate the prognostic significance of programmed cell death (PD)-1/PD-ligand 1 (PD-L1), PD-ligand 2 (PD-L2), and fibroblast growth factor receptor 3 (FGFR3) expression in bladder cancer (BC). Methods: A retrospective study was conducted on BC patients who underwent transurethral resection between 2005 and 2014.
Ana Blanca +6 more
openaire +3 more sources
Introduction: This study aimed to evaluate the prognostic significance of programmed cell death (PD)-1/PD-ligand 1 (PD-L1), PD-ligand 2 (PD-L2), and fibroblast growth factor receptor 3 (FGFR3) expression in bladder cancer (BC). Methods: A retrospective study was conducted on BC patients who underwent transurethral resection between 2005 and 2014.
Ana Blanca +6 more
openaire +3 more sources
Anti‐program cell death receptor‐1 induced erythema nodosum
Dermatologic Therapy, 2022Caroline Gerhardt +5 more
openaire +2 more sources
Veterinary Immunology and Immunopathology
Immunomodulatory antibody drugs that modulate the function of immune checkpoint molecules, such as programmed death receptor-1 (PD-1) and programmed cell death ligand 1 (PD-L1), have been established as new cancer treatments in human medicine. In recent years, there have also been reports on antibodies that inhibit immune checkpoint molecules in dogs ...
Takuya, Mizuno +3 more
openaire +2 more sources
Immunomodulatory antibody drugs that modulate the function of immune checkpoint molecules, such as programmed death receptor-1 (PD-1) and programmed cell death ligand 1 (PD-L1), have been established as new cancer treatments in human medicine. In recent years, there have also been reports on antibodies that inhibit immune checkpoint molecules in dogs ...
Takuya, Mizuno +3 more
openaire +2 more sources
Magyar onkologia, 2019
In the past years, immunotherapy emerged as a novel modality of clinical oncology. The development and introduction of immune checkpoint inhibitors required the development of companion diagnostics, the PD-L1 protein immunohistochemical tests. Unfortunately, almost all checkpoint inhibitors were exclusively validated by a specific PD-L1 in vitro ...
Gábor, Lotz +4 more
openaire +1 more source
In the past years, immunotherapy emerged as a novel modality of clinical oncology. The development and introduction of immune checkpoint inhibitors required the development of companion diagnostics, the PD-L1 protein immunohistochemical tests. Unfortunately, almost all checkpoint inhibitors were exclusively validated by a specific PD-L1 in vitro ...
Gábor, Lotz +4 more
openaire +1 more source
Programmed-cell-death-1-receptor-antagonists /rituximab
Reactions Weekly, 2022openaire +1 more source
Programmed cell-death-1-ligand-1 inhibitors/programmed cell-death-1-receptor antagonists
Reactions Weekly, 2020openaire +1 more source
Ipilimumab/programmed-cell-death-1-receptor-antagonists
Reactions Weekly, 2020openaire +2 more sources
Lenvatinib/programmed cell death-1 receptor antagonists
Reactions Weekly, 2022openaire +1 more source